{
  "meta": {
    "title": "A COVID Journal: An Infectious Diseases Pharmacist's Pandemic Chronicle",
    "author": "Steven Smoke",
    "generated": "2026-02-22",
    "description": "Structured chapter data extracted from the Covid-19 Timeline document for use in a React-based interactive website."
  },
  "chapters": [
    {
      "chapter_number": 1,
      "title": "The Before Times",
      "subtitle": "From First Reports to First Cases",
      "date_range": "December 12, 2019 – March 7, 2020",
      "anchor_date": "2019-12-12",
      "layout": "split",
      "mood": "Normalcy / Low-Alert",
      "mood_description": "A calm before the storm. Casual dismissal of early warning signs, life proceeding normally — Rutgers basketball, work trips, grocery runs.",
      "clinical_nodes": [
        {
          "date": "2019-12-12",
          "label": "First Cases",
          "content": "First reported cases of Covid-19 in Wuhan, China."
        },
        {
          "date": "Early January 2020",
          "label": "WHO Bulletin",
          "content": "Novel coronavirus (2019-nCoV) outbreak noted on Twitter / WHO. I dismiss it, citing precedent of Zika, Ebola, SARS, MERS not spreading substantially."
        },
        {
          "date": "2020-01-20",
          "label": "First US Case",
          "content": "First confirmed US case reported in Washington State."
        },
        {
          "date": "2020-01-24",
          "label": "AMS Prep Meeting",
          "content": "A colleague mentions coronavirus might be a big deal. I dismiss the idea as unlikely and unrelated to the AMS agenda."
        },
        {
          "date": "2020-02-12",
          "label": "ID / Infection Control Meeting",
          "content": "Novel coronavirus (nCoV-2019) officially renamed Covid-19. Topics: employee travel screening, mask shortage, testing protocols."
        },
        {
          "date": "2020-03-01",
          "label": "Puerto Rico Work Trip",
          "content": "Extended discussion with a Population Health physician during a flight delay about openness to travel amid the impending Covid-19 wave. He poses a hypothetical: would I travel in May?"
        },
        {
          "date": "2020-03-04",
          "label": "First NJ Case",
          "content": "First confirmed New Jersey case reported in Fort Lee."
        }
      ],
      "personal_nodes": [
        {
          "date": "Early January 2020",
          "label": "Dismissal",
          "content": "I see coronavirus news on Twitter and don't think much of it — mentally file it with prior outbreaks that 'never really spread.'"
        },
        {
          "date": "2020-02-16",
          "label": "Rutgers Basketball",
          "content": "Rutgers beats #21 Illinois. Program on track for first NCAA tournament berth in 30 years."
        },
        {
          "date": "2020-03-01",
          "label": "My Wife Prepares",
          "content": "While I'm in Puerto Rico, my wife begins preparing for a potential Covid-19 wave — first grocery haul and cleaning supplies."
        }
      ],
      "assets_wishlist": [
        "image10 — Opening/title graphic (large landscape image, likely a banner or logo)",
        "image6 — Washington state first case era photo",
        "image24 — Rutgers basketball win photo",
        "image29 — Puerto Rico trip photo (composite/collage style, portrait orientation)"
      ]
    },
    {
      "chapter_number": 2,
      "title": "The Run Up",
      "subtitle": "March 9–13, 2020: The Week Everything Changed",
      "date_range": "March 9, 2020 – March 13, 2020",
      "anchor_date": "2020-03-11",
      "layout": "split",
      "mood": "High-Alert / Acceleration",
      "mood_description": "Five days of cascading cancellations, first treatment emails, and the dawning realization that this is real. The world of sports collapses in real time.",
      "clinical_nodes": [
        {
          "date": "2020-03-09",
          "label": "First Remdesivir Email",
          "content": "The Chief Pharmacy Officer sends the first corporate email discussing remdesivir. Position: do not advocate without clinical trial data, but IND compassionate use is reasonable for highest-risk, critically ill patients."
        },
        {
          "date": "2020-03-11",
          "label": "ID / IC Meeting — A Warning Issued",
          "content": "An ID physician argues the system is moving too slowly: 'We need to prepare for what transmission will be, not what it currently is. We will be overrun.' The next 3 meetings are canceled."
        },
        {
          "date": "2020-03-11",
          "label": "First ID Pharmacy Collaborative Email",
          "content": "I send the inaugural email to the ID Pharmacy Collaborative sharing a treatment Google doc. Key assessments: Tamiflu unlikely to work; Remdesivir under NIH study; Chloroquine shows 'promising but questionable' evidence from China; Lopinavir/ritonavir retrospective shows no efficacy. I anticipate 'constantly changing evidence.'"
        },
        {
          "date": "2020-03-12",
          "label": "Call for Standard Algorithm",
          "content": "I email the AMS Chair, the Chief Pharmacy Officer, and Corporate Clinical Pharmacy leadership: 'We need a standard treatment algorithm.'"
        },
        {
          "date": "2020-03-13",
          "label": "First Draft Treatment Protocol",
          "content": "Our ID PharmD colleague sends a draft treatment protocol — revised 3-4 times in one day. Two pathways: one for ID-managed patients, one for surge overflow. Criteria: ICU / supplemental O2 / high-risk. Preferred: remdesivir compassionate use, then hydroxychloroquine. If ICU: sarilumab via trial or tocilizumab."
        },
        {
          "date": "2020-03-13",
          "label": "Pediatric ID Physician Remdesivir Inquiry",
          "content": "The Pediatric ID physician asks about the process to obtain remdesivir for pediatric use."
        }
      ],
      "personal_nodes": [
        {
          "date": "2020-03-09",
          "label": "Distracted by Covid",
          "content": "I'm supposed to be prepping for an ID society meeting presentation but can't focus — convinced this will be a major problem after seeing community transmission data from Washington State."
        },
        {
          "date": "2020-03-11",
          "label": "NBA Positive Test",
          "content": "An NBA player tests positive; the NBA season is suspended."
        },
        {
          "date": "2020-03-12",
          "label": "Big Ten Tournament Canceled",
          "content": "The B10 tournament is canceled while Rutgers is on the court warming up. The NHL season is also suspended. The Rutgers tournament dream dies."
        },
        {
          "date": "2020-03-13",
          "label": "NCAA March Madness Canceled",
          "content": "NCAA March Madness officially canceled."
        },
        {
          "date": "2020-03-11",
          "label": "ID Society Meeting Canceled",
          "content": "The state infectious diseases society cancels its meeting."
        }
      ],
      "assets_wishlist": [
        "image37 — Misc photo from ~March 9 (landscape, medium size)",
        "image12 — Photo associated with March 12 Big Ten / NHL cancellations"
      ]
    },
    {
      "chapter_number": 3,
      "title": "Exponential Growth",
      "subtitle": "The Hydroxychloroquine Wars",
      "date_range": "March 14 – April 8, 2020",
      "anchor_date": "2020-03-19",
      "layout": "split",
      "mood": "Chaos / Urgency",
      "mood_description": "A frantic three weeks of evolving guidelines, drug shortages, political interference, Twitter misinformation, and inter-physician conflict over HCQ dosing. The science is moving faster than anyone can track.",
      "clinical_nodes": [
        {
          "date": "2020-03-14",
          "label": "Ibuprofen Controversy",
          "content": "The French Health Minister tweets that ibuprofen could be an aggravating factor. Anecdotal and pharmacological speculation, not evidence-based. WHO temporarily recommends against ibuprofen; WHO and EMA later retract on 3/19."
        },
        {
          "date": "2020-03-15",
          "label": "HCQ Stockpile Revealed",
          "content": "The Chief Pharmacy Officer shares that our health system has stockpiled hydroxychloroquine and requests an algorithm for distribution."
        },
        {
          "date": "2020-03-16",
          "label": "HCQ Protocol Version 3",
          "content": "Our ID PharmD colleague sends updated recommendations: HCQ for most eligible patients, remdesivir via clinical trial if mechanically ventilated, IL-6 antagonist if ARDS. The AMS distributes the first formal guidance (Version 3)."
        },
        {
          "date": "2020-03-16",
          "label": "Steroids Debate Begins",
          "content": "I share a JAMA retrospective suggesting steroids may help; CDC and WHO recommend against them at this time. Later proven to reduce mortality."
        },
        {
          "date": "2020-03-17",
          "label": "First Staff Pharmacist Presentation",
          "content": "I give my first Covid-19 presentation to staff pharmacists. Packed room. Most questions cannot be answered."
        },
        {
          "date": "2020-03-18",
          "label": "NEJM: Lopinavir/r Not Effective",
          "content": "NEJM RCT published: lopinavir/ritonavir not effective for Covid-19. Removed from future protocol versions."
        },
        {
          "date": "2020-03-19",
          "label": "French HCQ Study Circulates",
          "content": "An ID physician shares the French HCQ/azithromycin study — not yet published or peer-reviewed. Debate begins on dosing, azithromycin addition, and QTc monitoring. The President calls HCQ 'a game changer' at a press conference. Azithromycin goes on ASHP shortage."
        },
        {
          "date": "2020-03-20",
          "label": "HCQ Use 'Out of Control'",
          "content": "I note in an email: 'well our use is starting to get out of control.' First daily HCQ tracking reports begin."
        },
        {
          "date": "2020-03-20",
          "label": "First Compassionate Use Approved",
          "content": "My first Gilead compassionate use remdesivir request, submitted on behalf of an ICU physician, is approved."
        },
        {
          "date": "2020-03-25",
          "label": "HCQ Duration Curtailed",
          "content": "Greater than 5-day HCQ duration discouraged due to limited evidence and supply constraints."
        },
        {
          "date": "2020-03-27",
          "label": "Azithromycin Recommendation Challenged",
          "content": "My ID PharmD colleague and I draft an SBAR to pull azithromycin from the protocol citing: no prior evidence, non-equivalent control group, no clinical benefit demonstrated, and potential QTc toxicity."
        },
        {
          "date": "2020-03-28",
          "label": "HCQ Dosing Conflict",
          "content": "An ID physician emails the CEO, CMO, and Chair of Medicine demanding higher HCQ dosing based on a retrospective, non-comparative French follow-up study. I provide pushback via email. The physician calls me immediately, claiming I had 'stabbed him in the back.'"
        },
        {
          "date": "2020-03-28",
          "label": "FDA Emergency Use Authorization",
          "content": "FDA issues EUA for chloroquine and hydroxychloroquine."
        },
        {
          "date": "2020-04-01",
          "label": "Tocilizumab Outcomes Concerning",
          "content": "Suspicion that tocilizumab is being used too late — very few positive outcomes observed."
        },
        {
          "date": "2020-04-08",
          "label": "Guidelines Updated Again",
          "content": "Updated guidelines: HCQ duration extended to 5-7 days, tocilizumab criteria broadened, anticoagulation and steroids formally addressed."
        }
      ],
      "personal_nodes": [
        {
          "date": "2020-03-14",
          "label": "A Friend's 50th Birthday Skipped",
          "content": "After mutual friends decided not to attend, I email a friend that my wife and I won't attend a 50th birthday gathering due to Covid-19. Our friend's parents later end up in the ICU; her father passes away."
        },
        {
          "date": "2020-03-16",
          "label": "My Wife Works From Home",
          "content": "My wife begins working from home."
        },
        {
          "date": "2020-03-17",
          "label": "Reading Chinese Papers",
          "content": "'Trying to read all of these Chinese papers' — I use Google Translate on foreign-language studies to keep up with global evidence."
        },
        {
          "date": "2020-03-21",
          "label": "NJ Closes Nonessential Businesses",
          "content": "New Jersey closes nonessential businesses."
        },
        {
          "date": "2020-03-22",
          "label": "Emails From Strangers",
          "content": "I receive an email from a new attending physician about the guidelines. Over the following weeks, I receive emails from physicians in NYC and India — both unaffiliated with our health system — because the guidelines included my contact info."
        },
        {
          "date": "2020-04-03",
          "label": "Oval Office Meeting",
          "content": "An ID physician meets with the President, a TV host, and the FDA Director to pressure HCQ authorization."
        },
        {
          "date": "2020-04-04",
          "label": "Video Call With My Wife",
          "content": "My wife is grocery shopping online; we're communicating via Zoom. The kids are 'living their best life making mud soup.' My wife's knuckles are cracked from hand sanitizing. I'm not yet wearing a mask at work — the CDC hadn't recommended it for healthcare workers yet. 'We're just a covid hospital, every unit is an ICU, no one knows how to treat it, people want to try everything.' 'My music selection is a good indicator of my mental state — I've been listening to emo like it's 2005.'"
        }
      ],
      "assets_wishlist": [
        "image13 — Photo from early March (large landscape, likely NJ/hospital context)",
        "image14 — Photo from early March (medium landscape)",
        "image36 — Photo from March 18 area",
        "image23 — CBMC Physician Discussion era photo (large, portrait)",
        "image15 — Misc late March photo (large landscape)",
        "image37 — Misc photo",
        "image31 — Photo associated with steroids/tocilizumab discussion",
        "image30 — Photo associated with April 1 area",
        "image3 — Recurring small portrait image (appears repeatedly — likely a bar chart or case tracker screenshot)",
        "image4 — Recurring chart image (appears many times — likely the NJ Covid case curve chart)"
      ]
    },
    {
      "chapter_number": 4,
      "title": "The Dark Ages",
      "subtitle": "The Surge, the Silence, and the Trailers",
      "date_range": "April 9 – May 31, 2020",
      "anchor_date": "2020-04-15",
      "layout": "split",
      "mood": "Isolation / Grief",
      "mood_description": "The hospital empties of non-essential staff but fills with the dying. Empty hallways. Refrigerated trailers in the parking lot. Clap-outs. 'Here Comes the Sun.' Tooth-grinding stress. An overwhelming sense of hopelessness on the morning commute.",
      "clinical_nodes": [
        {
          "date": "2020-04-11",
          "label": "HCQ Skepticism Grows",
          "content": "A NEJM quasi-experimental HCQ study circulates. The first serious discussion in the ID pharmacy group of pulling the HCQ recommendation entirely. The group notes that stopping azithromycin 'wasn't as bad as expected.'"
        },
        {
          "date": "2020-04-11",
          "label": "Ivermectin: First and Last (for 8 months)",
          "content": "Two ID physicians separately ask about ivermectin. I explain that concentrations required for efficacy are orders of magnitude above what can be safely achieved. No more ivermectin questions for eight months."
        },
        {
          "date": "2020-04-17",
          "label": "Tocilizumab: Earlier May Be Better",
          "content": "Preliminary tocilizumab results suggest earlier administration may be more effective — consistent with our clinical suspicion."
        },
        {
          "date": "2020-04-24",
          "label": "NIH Guidelines Adopted",
          "content": "Our AMS decides guidelines will mirror NIH guidelines going forward — requiring a much higher evidence threshold before making recommendations. No recommended therapies at this point."
        },
        {
          "date": "2020-04-27",
          "label": "HCQ Pulled From Guidelines",
          "content": "The HCQ recommendation is officially removed from our guidelines based on NIH and IDSA guidance."
        },
        {
          "date": "2020-04-29",
          "label": "Remdesivir: Contradictory Data",
          "content": "A Chinese remdesivir RCT in Lancet shows no benefit. The same day, NIAID shares (unpublished, non-peer-reviewed) data from its RCT indicating benefit. 'Timing causes considerable confusion.'"
        },
        {
          "date": "2020-05-01",
          "label": "Remdesivir EUA",
          "content": "FDA issues emergency use authorization for remdesivir."
        },
        {
          "date": "2020-05-08",
          "label": "Anakinra Early Data",
          "content": "First retrospective cohort data on anakinra published in The Lancet. I note it 'looks better than toci data.' Tocilizumab use is dropping significantly."
        },
        {
          "date": "2020-05-08",
          "label": "HCQ NEJM Study: No Benefit",
          "content": "A large observational study published in NEJM finds no benefit from hydroxychloroquine."
        },
        {
          "date": "2020-05-15",
          "label": "First Remdesivir Shipment",
          "content": "26 courses of remdesivir arrive around 6-7pm. An ID physician pre-emptively enters ~10 orders that evening; most are on patients admitted long ago, unlikely to benefit."
        },
        {
          "date": "2020-05-22",
          "label": "HCQ Gated to Clinical Trial",
          "content": "A P&T memo to Medical Staff states: HCQ for Covid-19 must go through a clinical trial. Non-trial use permitted only if a patient is ineligible. The ID physician responds calling it 'Tuskegee type illegal.'"
        }
      ],
      "personal_nodes": [
        {
          "date": "Circa April 2020",
          "label": "The Hospital Empties",
          "content": "Non-essential personnel work from home. Empty hallways and cafeteria. The hospital receives donations: food, drinks, hand sanitizers from distilleries, handwritten letters from children, mask comfort adapters."
        },
        {
          "date": "Circa April 2020",
          "label": "Trailers in the Parking Lot",
          "content": "The hospital morgue fills. Two refrigerated trailers are placed in the physician parking lot for overflow bodies. They remained for months. Every employee saw them going in and out each day."
        },
        {
          "date": "Circa April 2020",
          "label": "'Here Comes the Sun'",
          "content": "The Beatles song is played over the hospital loudspeaker each time a patient is extubated. Sound quality described as horrendous."
        },
        {
          "date": "Circa April 2020",
          "label": "Clap-Outs",
          "content": "Staff line the halls and applaud patients discharged after weeks- or months-long admissions."
        },
        {
          "date": "Circa April 2020",
          "label": "Tooth-Grinding",
          "content": "I notice mild, persistent tooth pain — eventually realizing it is from clenching my jaw. A subconscious physical response to facing unanswerable questions with lives on the line."
        },
        {
          "date": "Circa April 2020",
          "label": "Morning Commute Grief",
          "content": "'I remember getting emotional a few times. It was always on my morning commute... I remember feeling an overwhelming hopelessness. Not just for myself and all the patients and their families. But for everyone I care about and how isolated and scared they must be.'"
        },
        {
          "date": "Circa April 2020",
          "label": "Hotel Stay",
          "content": "I move into a hotel from April 7 to April 18 to protect my family."
        },
        {
          "date": "Circa April 2020",
          "label": "My Wife's Knit Mask",
          "content": "My wife handknits a mask for me to use outside the hospital, since there weren't enough for non-healthcare workers. 'It probably didn't work that well but it meant a lot to me that she worked on it for me.'"
        },
        {
          "date": "Circa April 2020",
          "label": "My Wife Cuts My Hair",
          "content": "My wife cuts my hair. It takes three attempts and two hours, but turns out well. I have jealous coworkers."
        },
        {
          "date": "Circa April 2020",
          "label": "CDI Plummets, Fungal Infections Rise",
          "content": "Hospital CDI (C. diff) rates plummet due to dramatically improved hand hygiene. Fungal infections, MRSA, and other hospital-acquired infections rise due to the surge in critically ill patients with prolonged stays."
        }
      ],
      "assets_wishlist": [
        "image5 — Photo from ~April 9 area (small portrait, likely hospital/clinical)",
        "image35 — Photo from April 11 area (medium landscape)",
        "image19 — Photo from April 11 area (small portrait, likely ivermectin-era)",
        "image44 — Photo from April 13",
        "image39 — Photo from April 30 (medium portrait)",
        "image40 — Photo from April 29 area (wide landscape)",
        "image20 (x2) — Email/memo screenshots associated with April 2 and the HCQ trial gating memo"
      ]
    },
    {
      "chapter_number": 5,
      "title": "The MAB Graveyard",
      "subtitle": "The Monoclonal Antibody Arms Race",
      "date_range": "July 2, 2020 – November 30, 2022",
      "anchor_date": "2020-11-09",
      "layout": "full",
      "mood": "Hope / Attrition",
      "mood_description": "A two-year arc of approved monoclonal antibodies — each arriving with promise, each eventually rendered obsolete by viral mutation. A clinical arms race the virus ultimately wins.",
      "clinical_nodes": [
        {
          "date": "2020-07-02",
          "label": "Sarilumab Fails Primary Endpoint",
          "content": "Regeneron reports the sarilumab study fails to meet its primary endpoint. Criteria was too broad, including circumstances where the drug is ineffective. Later proven effective in more targeted use. Regeneron pivots to a monoclonal antibody targeting the spike protein."
        },
        {
          "date": "2020-09-20",
          "label": "First Compassionate Use: Casirivimab/Imdevimab",
          "content": "I work with the Pediatric ID physician on the first (of at least two) compassionate use requests for Regeneron's casirivimab/imdevimab in a pediatric patient."
        },
        {
          "date": "2020-10-02",
          "label": "The President Receives Casirivimab/Imdevimab",
          "content": "The President publicly discloses he has Covid-19 and receives casirivimab/imdevimab via compassionate use. This brings considerable media attention to the medication."
        },
        {
          "date": "2020-11-09",
          "label": "Bamlanivimab EUA Granted",
          "content": "FDA grants EUA for bamlanivimab. Immediate discussions about where to administer it — a pharmacy colleague and I suggest the ED. The system decides on EDs by November 16."
        },
        {
          "date": "2020-11-18",
          "label": "Bamlanivimab Dispensing Begins",
          "content": "Our hospital begins dispensing bamlanivimab."
        },
        {
          "date": "2020-11-21",
          "label": "Casirivimab/Imdevimab EUA",
          "content": "FDA grants EUA for casirivimab/imdevimab (Regeneron). Both 'bam' and 'Regeneron' are used simultaneously based on inconsistent supply."
        },
        {
          "date": "2021-02-09",
          "label": "Bamlanivimab/Etesevimab EUA",
          "content": "FDA grants EUA for the combination. Rationale: resistance to bamlanivimab suspected in circulating variants; etesevimab intended to restore activity. Variant monitoring becomes essential to treatment decisions."
        },
        {
          "date": "2021-02-09",
          "label": "Mutation Reckoning",
          "content": "I reflect on my prior dismissal of mutation concerns: 'This was very wrong.' My first concern was the Alpha variant (UK), more transmissible but not affecting MAB activity. Then variants emerged worldwide."
        },
        {
          "date": "2021-04-16",
          "label": "Bamlanivimab Alone EUA Revoked",
          "content": "EUA for single-agent bamlanivimab revoked due to variant resistance."
        },
        {
          "date": "2021-05-26",
          "label": "Sotrovimab EUA",
          "content": "FDA grants EUA for sotrovimab."
        },
        {
          "date": "2022-01-26",
          "label": "Casirivimab/Imdevimab and Bamlanivimab/Etesevimab EUAs Revoked",
          "content": "Both EUAs revoked due to variant resistance."
        },
        {
          "date": "2022-02-11",
          "label": "Bebtelovimab EUA",
          "content": "FDA grants EUA for bebtelovimab despite 'basically no clinical data.'"
        },
        {
          "date": "2022-03-25",
          "label": "Sotrovimab EUA Restricted",
          "content": "Sotrovimab EUA revised to exclude areas with high BA.2 prevalence, including New Jersey. Later fully revoked."
        },
        {
          "date": "2022-11-30",
          "label": "Bebtelovimab EUA Revoked — The Virus Wins",
          "content": "Bebtelovimab, the last available monoclonal antibody, has its EUA revoked. 'The virus has won the arms race.'"
        }
      ],
      "personal_nodes": [
        {
          "date": "2020-11-11",
          "label": "MAB Paper Submitted",
          "content": "My MAB paper is submitted to the Journal of Medical Virology after rejection from many journals."
        },
        {
          "date": "2022-02-20",
          "label": "MAB Paper Published",
          "content": "My MAB paper is officially published in the Journal of Medical Virology."
        }
      ],
      "assets_wishlist": [
        "image1 — Large wide graphic at the end of MAB section (full-page width image)",
        "image41 — Photo after MAB timeline (medium landscape)",
        "image38 — Photo after MAB timeline (medium landscape)",
        "image27 — Photo after MAB timeline (medium landscape)"
      ]
    },
    {
      "chapter_number": 6,
      "title": "Vaccination Peregrination",
      "subtitle": "From 50% Threshold to 300 Shots",
      "date_range": "Summer 2020 – Spring 2021",
      "anchor_date": "2020-12-21",
      "layout": "split",
      "mood": "Hope / Joy",
      "mood_description": "A rare chapter of optimism in a dark year. The arrival of vaccines — 90% efficacy news that blew everyone away — and the shared joy of vaccination clinics. Pharmacists give hope a shot.",
      "clinical_nodes": [
        {
          "date": "2020-06-30",
          "label": "FDA Vaccine Efficacy Threshold",
          "content": "FDA publishes guidance for industry: a Covid-19 vaccine must demonstrate at least 50% efficacy to receive authorization."
        },
        {
          "date": "2020-09-11",
          "label": "A Pharmacy Leader Cautions Against Vaccine",
          "content": "A prominent pharmacy administrator emails a large listserv urging extreme caution: recommends waiting for full FDA approval PLUS 6 months of post-marketing data before vaccinating. Advises pharmacists to carry liability insurance."
        },
        {
          "date": "2020-10-06",
          "label": "FDA: Two Months Safety Data Required",
          "content": "FDA announces it requires two months of safety data before issuing any vaccine EUA, effectively eliminating the possibility of pre-election approval."
        },
        {
          "date": "2020-10-09",
          "label": "Vaccine Task Force Formed",
          "content": "First email from the Chief Pharmacy Officer about an internal vaccine task force formation."
        },
        {
          "date": "2020-11-09",
          "label": "Pfizer 90% Efficacy Announced",
          "content": "A PGY1 resident tells me the news: the Pfizer vaccine is 90% effective. 'I remember being blown away. Thrilled.' All experts were similarly stunned by the magnitude of efficacy."
        },
        {
          "date": "2020-12-10",
          "label": "I Watch the FDA VRPAC Meeting",
          "content": "I watch most of the FDA Vaccines and Related Biological Products Advisory Committee meeting on the Pfizer vaccine. I will watch many more VRPAC and ACIP meetings over the next year."
        },
        {
          "date": "2020-12-11",
          "label": "Pfizer EUA Granted",
          "content": "FDA grants EUA for the Pfizer-BioNTech Covid-19 vaccine."
        },
        {
          "date": "2020-12-14",
          "label": "I Get My Pharmacist Immunizer License",
          "content": "I obtain my pharmacist immunizer license."
        },
        {
          "date": "2020-12-18",
          "label": "Moderna EUA Granted",
          "content": "FDA grants EUA for the Moderna Covid-19 vaccine."
        },
        {
          "date": "2020-12-21",
          "label": "First Vaccines at the Hospital",
          "content": "First day of vaccine administration at our hospital. I'm vaccinated at 5pm — an hour after the clinic is scheduled to close — as the vaccine team looks for volunteers to use up remaining doses. I was not in the first priority group."
        },
        {
          "date": "2020-12-23",
          "label": "I Start Vaccinating",
          "content": "My first day administering vaccinations. Initially staff only, then the public. I provide over 300 vaccinations over the next four months at our hospital, a county vaccination site at a former mall, and an elementary school gym."
        }
      ],
      "personal_nodes": [
        {
          "date": "Summer 2020",
          "label": "NEJM Podcast Revelation",
          "content": "I start listening to the NEJM Interviews podcast — weekly Covid-19 literature updates. My first realization that vaccine mandates might happen, that this would be the biggest vaccination campaign in history, and that I need to get licensed to vaccinate."
        },
        {
          "date": "2020-11-09",
          "label": "Missed the Tweet",
          "content": "I was upset I missed the Pfizer 90% efficacy tweet — a resident was the one who told me. I had been checking Twitter 2-4x per day all year."
        },
        {
          "date": "2020-12-23",
          "label": "Joy at the Vaccine Clinic",
          "content": "'I remember the shared sense of positivity, excitement and joy among the vaccinators and public. Everyone was happier than they had been in nearly a year.'"
        },
        {
          "date": "2020-12-23",
          "label": "Notable Vaccinees",
          "content": "I vaccinate the Chair of Medicine and several physicians I work with. I also vaccinate an NHL player and some minor league players. I supervise technicians vaccinating a first-round NHL draft pick."
        },
        {
          "date": "Late December 2020",
          "label": "The CPO Calls Before a TV Appearance",
          "content": "The Chief Pharmacy Officer calls me 20 minutes before a television appearance asking how to explain how the vaccines work."
        }
      ],
      "assets_wishlist": [
        "image21 — Photo from November 9, 2020 (medium portrait, likely Pfizer news era)",
        "image25 — Photo from FDA VRPAC meeting December 10 (wide landscape)",
        "image34 — Photo from Moderna EUA area (medium landscape)",
        "image9 — Photo from first vaccination day, December 21 (medium portrait)",
        "image33 — Photo from vaccination clinic era (small portrait)",
        "image42 — Photo from late December / CPO TV call era (medium landscape)"
      ]
    },
    {
      "chapter_number": 7,
      "title": "Fox and Friends",
      "subtitle": "The HCQ Conflict Comes to a Head",
      "date_range": "December 10, 2020 – June 8, 2021",
      "anchor_date": "2021-06-01",
      "layout": "full",
      "mood": "Conflict / Vindication",
      "mood_description": "A concentrated drama centered on one physician's continued advocacy for hydroxychloroquine after the evidence had turned against it — culminating in a Fox News appearance where I am named by an ID physician, and the COO privately drops f-bombs in my defense.",
      "clinical_nodes": [
        {
          "date": "2020-12-10",
          "label": "P&T Memo: HCQ Prohibited",
          "content": "I work with the CMO, the Pharmacy Director, and the Associate Director on a P&T memo to stop HCQ use for Covid-19. The ID division votes on prohibition — passes by a narrow margin. The ID co-chair is completely unaware of the process; he does not check email."
        },
        {
          "date": "2021-02-05",
          "label": "CMO vs. ID Physician Over HCQ Ban",
          "content": "The CMO and the ID physician clash directly over the HCQ ban."
        },
        {
          "date": "2021-06-01",
          "label": "Fox News Appearance — My Name Used",
          "content": "The ID physician returns to Fox News claiming his unpublished, retrospective study proves hydroxychloroquine works. He names me by name on national television: 'I turned to the pharmacist, Steve Smoke at St. Barnabas and I said, I got people that are literally more than four times difference in weight, one or both groups is getting the wrong dose.' The study is vastly inferior to available evidence and — to my knowledge — was never published."
        },
        {
          "date": "2021-06-08",
          "label": "Vindication: UTI Pathway Praised",
          "content": "The Chair of Medicine sends an email praising my work on an unrelated UTI antimicrobial stewardship pathway to the CEO, CFO, and CMO. The CMO responds in agreement."
        },
        {
          "date": "2021-06-08",
          "label": "COO Private Support",
          "content": "The COO comes down to my office for a private conversation. Says the institution supports me, that I shouldn't have to deal with what happened, and drops some f-bombs about the ID physician."
        },
        {
          "date": "2020-06-05",
          "label": "RECOVERY Trial: HCQ No Benefit",
          "content": "The RECOVERY trial determines no benefit from hydroxychloroquine in hospitalized Covid-19 patients. I distribute the details and clinical trial contact info to ID physicians."
        },
        {
          "date": "2020-06-15",
          "label": "HCQ EUA Revoked",
          "content": "FDA officially revokes the emergency use authorization for hydroxychloroquine."
        },
        {
          "date": "2020-06-16",
          "label": "RECOVERY Trial: Dexamethasone Reduces Mortality",
          "content": "The RECOVERY trial reports dexamethasone reduces mortality — a landmark finding. Questions arise about whether a trial report (not peer-reviewed) is sufficient to change practice. Our system waits for the NIH guideline update but the CPO is pressured by an ID physician to act sooner."
        },
        {
          "date": "2020-12-01",
          "label": "Ivermectin Returns — Physician Confrontation",
          "content": "Two ID physicians order ivermectin. I push back. One is very rude: 'How dare you?… I've been practicing medicine for X years…' The physician compares the situation to bamlanivimab. Bamlanivimab is later proven effective; ivermectin is not."
        }
      ],
      "personal_nodes": [
        {
          "date": "2021-06-01",
          "label": "Named on TV",
          "content": "I am named by an ID physician on Fox News in the context of a disagreement over HCQ dosing methodology. The clip and transcript are preserved as external links."
        },
        {
          "date": "2021-06-08",
          "label": "COO Drops F-Bombs",
          "content": "The hospital COO visits my office privately to offer personal support and express frustration with the ID physician."
        },
        {
          "date": "2021-04-13",
          "label": "HCQ Paper Accepted",
          "content": "My hydroxychloroquine paper is accepted for publication (submitted in February 2021, after rejection from several journals)."
        },
        {
          "date": "2020-08-03",
          "label": "Opinion Article Published",
          "content": "My opinion article is published in Pharmacy Practice News. Key themes: difficulty determining what therapies work; misinformation from the messy scientific process being in the spotlight; importance of humility and saying 'I don't know'; the essential role of patients volunteering for RCTs."
        }
      ],
      "assets_wishlist": [
        "image26 — Photo associated with February 5, 2021 CMO/ID physician confrontation (large landscape)",
        "image7 — Screenshot or memo image from May 22, 2020 HCQ/CINJ trial gating memo",
        "image8 — Screenshot or document image from December 3, 2020",
        "image28 — Photo from July 30, 2020 area (large landscape)",
        "image2 — Image from HCQ paper submission / acceptance area",
        "image11 — Image from June 5, 2020 (RECOVERY trial period, wide landscape)",
        "image16 — Portrait image from April 4 area (likely personal/family photo)",
        "image22 — Photo from March 25, 2022 area (MAB/Sotrovimab period, wide landscape)"
      ]
    }
  ]
}
